Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-migraine agents from an immunological point of view
Mushref Bakri Assas
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Nutrients to Improve Mitochondrial Function to Reduce Brain Energy Deficit and Oxidative Stress in Migraine
Michał Fila, Cezary Chojnacki, Jan Chojnacki, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4433-4433
Open Access | Times Cited: 63
Neuropeptide signalling orchestrates T cell differentiation
Yu Hou, Lin-Yu Sun, Martin W. LaFleur, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 444-452
Closed Access | Times Cited: 12
Inflammatory complications of CGRP monoclonal antibodies: a case series
Jason C. Ray, Penelope J. Allen, Ann Bacsi, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 48
The neuropeptide CGRP enters the macrophage cytosol to suppress the NLRP3 inflammasome during pulmonary infection
Fangrui Zhu, Yu Dou, Xiwen Qin, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 3, pp. 264-276
Open Access | Times Cited: 19
Migraine: Advances in the Pathogenesis and Treatment
Horia Pleș, Ioan Alexandru Florian, Teodora-Larisa Timiș, et al.
Neurology International (2023) Vol. 15, Iss. 3, pp. 1052-1105
Open Access | Times Cited: 18
Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms
Leonardo Biscetti, Gioacchino De Vanna, Elena Cresta, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 39
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders
Michał Fila, Jan Chojnacki, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10134-10134
Open Access | Times Cited: 36
Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials
Marcello Silvestro, Ilaria Orologio, Mattia Siciliano, et al.
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 2, pp. 79-96
Closed Access | Times Cited: 11
The evolving concept of multimorbidity and migraine
Claudia Altamura, Gianluca Coppola, Fabrizio Vernieri
Handbook of clinical neurology (2024), pp. 535-566
Closed Access | Times Cited: 3
AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
Marika Marino, Matthew G. Holt
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 13
Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes
Jiamin Zheng, Dongdong Chen, Jie Xu, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 48, pp. 128229-128229
Closed Access | Times Cited: 13
Xiongshao Zhitong Recipe Attenuates Nitroglycerin-Induced Migraine-Like Behaviors via the Inhibition of Inflammation Mediated by Nitric Oxide Synthase
Yang Song, Cong Chen, Xiaoyao Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Treatment of migraine with monoclonal antibodies
José M. Serra López-Matencio, Ana Beatriz Gago‐Veiga, Manuel Gómez, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 707-716
Closed Access | Times Cited: 8
Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis
Ashley Mason, Lauren Fragapane, Zuleyma Toledo-Nieves, et al.
International Journal of MS Care (2023) Vol. 26, Iss. 3, pp. 104-107
Open Access | Times Cited: 4
Recent preclinical study offers a promising clue: Role of regulatory T cells as biomarkers in migraine
Murugesan Arumugam, Sugin Lal Jabaris S
Immunology Letters (2021) Vol. 240, pp. 9-11
Closed Access | Times Cited: 7
The ratio of alpha-calcitonin gene-related peptide to substance P is associated with the transition of bone metabolic states during aging and healing
Qianzi Liu, Minxuan Yu, Menglin Liao, et al.
Journal of Molecular Histology (2023) Vol. 54, Iss. 6, pp. 689-702
Closed Access | Times Cited: 2
New Migraine Drugs for Older Adults
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, et al.
Drugs & Aging (2023) Vol. 40, Iss. 4, pp. 301-305
Closed Access | Times Cited: 1
Correction to: Anti-migraine agents from an immunological point of view
Mushref Bakri Assas
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Neuropeptide stimulation of physiological and immunological responses in precision‐cut lung slices
Brielle H Patlin, Luke Schwerdtfeger, Stuart A. Tobet
Physiological Reports (2023) Vol. 11, Iss. 22
Open Access
CRISPR screens reveal neuropeptide signaling orchestrates T helper cell differentiation
Vijay K. Kuchroo, Yu Hou, Martin W. LaFleur, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top